Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 06, 2018
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients.
Journal: Journal of oncology practice
Published: October 06, 2017
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 15, 2017
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 15, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026